Key Takeaways & Executive Findings
- •• Low-frequency repetitive transcranial magnetic stimulation (rTMS) over the right Broca's area significantly improves language function in post-stroke non-fluent aphasia, particularly in spontaneous speech, auditory comprehension, and naming. • Transcranial direct current stimulation (tDCS) over bilateral Broca's area is most effective for enhancing daily communication abilities in aphasia patients. • Network meta-analysis identified optimal non-invasive neuromodulation protocols among 10 techniques, with low-frequency rTMS and bilateral tDCS showing superior outcomes. • The overall evidence level is low due to limitations in study quantity and quality, necessitating further high-quality randomized controlled trials.
Abstract
OBJECTIVE: Many studies have shown that non-invasive neuromodulation techniques can effectively improve the symptoms of non-fluent aphasia after stroke. However, the optimal stimulation protocols for these techniques still need to be further verified and explored. This article used a network meta-analysis method to systematically evaluate the effects of different non-invasive neuromodulation techniques on improving the language function of patients with non-fluent aphasia after stroke. METHODS: The CNKI, WanFang, VIP, CBM, PubMed, Cochrane Library, Embase, and Web of Science databases were searched for randomized controlled trials on the treatment of non-fluent aphasia after stroke with non-invasive neuromodulation techniques, with the search deadline of June 1, 2025. The control group received conventional treatment or sham stimulation, while the experimental group received non-invasive neuromodulation techniques in addition to the control treatment. Outcome measures included the Western Aphasia Battery, Chinese Aphasia Battery, and Communicative Abilities in Daily Living Scale. Stata 17.0 software was used for traditional meta-analysis and network meta-analysis, and GRADE was used to evaluate the evidence level of outcome measures. RESULTS: A total of 33 randomized controlled trials involving 10 non-invasive neuromodulation methods were included. (1) Traditional meta-analysis results showed that low-frequency repetitive transcranial magnetic stimulation (rTMS) over the right Broca's area, transcranial direct current stimulation (tDCS) over bilateral Broca's area, and tDCS over the left Broca's area improved Western Aphasia Battery scores (P < 0.001); low-frequency rTMS over the right Broca's area, low-frequency rTMS over the posterior superior temporal gyrus, and low-frequency rTMS over the right Broca's area combined with high-frequency rTMS over the left Broca's area improved Chinese Aphasia Battery scores (P < 0.05); low-frequency rTMS over the right Broca's area, tDCS over bilateral Broca's area, continuous theta burst stimulation over the right Broca's area combined with intermittent theta burst stimulation over the left Broca's area, high-frequency rTMS over the right Broca's area, and low-frequency rTMS over the right Broca's area combined with high-frequency stimulation over the left Broca's area improved Communicative Abilities in Daily Living Scale scores (P < 0.05). (2) Network meta-analysis results showed that low-frequency rTMS over the right Broca's area was more effective in improving Western Aphasia Battery scores [SMD=1.13, 95%CI(0.59, 1.67), P < 0.05] and Chinese Aphasia Battery scores [SMD=4.73, 95%CI(1.28, 8.18), P < 0.05], while tDCS over bilateral Broca's area was more effective in improving Communicative Abilities in Daily Living Scale scores [SMD=1.81, 95%CI(0.51, 2.12), P < 0.05]. (3) GRADE evidence level evaluation showed that the evidence levels for Western Aphasia Battery, Chinese Aphasia Battery, and Communicative Abilities in Daily Living Scale outcome measures were all low. CONCLUSION: Different non-invasive neuromodulation techniques can improve the language function of patients with non-fluent aphasia after stroke. Low-frequency rTMS over the right Broca's area has significant efficacy in improving multi-dimensional language function, especially in spontaneous speech coherence, auditory comprehension accuracy, and naming fluency; tDCS over bilateral Broca's area is more focused on improving patients' daily communication ability. However, the results are affected by the quantity and quality of included studies, and the evidence level is low, requiring more high-quality studies for further verification.
1. Introduction
Approximately one-third of patients experience speech dysfunction after stroke, with the pathological basis being damage to the language centers in the dominant hemisphere, making it more common than Parkinson's disease and muscular dystrophy [1]. Non-fluent aphasia is a common type of post-stroke aphasia, accounting for 41.25% of aphasia cases, and is closely related to lesions in the left inferior frontal gyrus. It is characterized by effortful speech, reduced verbal output, frequent pauses, and non-fluent sentence production, encompassing various types such as motor aphasia, transcortical motor aphasia, and global aphasia [2]. The impact of aphasia extends beyond language function, posing challenges in emotional well-being, social participation, and the ability to return to work [3].
Currently, clinical treatment primarily involves conventional speech training combined with medications, acupuncture, and manual therapy to improve post-stroke speech disorders. For example, drugs such as donepezil, memantine, and piracetam are often used in conjunction with speech training [4-5]. In recent years, neuromodulation techniques have developed rapidly, expanding from initial applications in stroke-related limb dysfunction to the treatment of depression, Parkinson's disease, and Alzheimer's disease [6-9]. Non-invasive neuromodulation techniques mainly include repetitive transcranial magnetic stimulation (rTMS), transcranial direct current stimulation (tDCS), theta burst stimulation, and transcranial alternating current stimulation. These techniques are easy to operate and have low risk, showing significant application potential in the clinical intervention of post-stroke aphasia [10]. Current research [11-13] has demonstrated that non-invasive neuromodulation can improve language function in aphasia patients, but the optimal stimulation parameters and protocols remain to be determined.
Loading authentic research manuscript (Pages 1–5)...
Li Sihui, Wang Qin, Cui Shenhong, Cheng Xiaofei, Feng Ziyun, Wang Dehua, Liang Chunting, Leng Jun (2026). A network meta-analysis of effects of non-invasive neuromodulation techniques on language function in patients with aphasia after stroke. Chinese Journal of Tissue Engineering Research. https://doi.org/10.12307/2026.21375
Research & Educational Purpose Only:The translations, structured abstracts, analytical annotations, and data reports provided by SinoBioData are intended exclusively for academic research, internal corporate R&D, and educational benchmarking. They do not constitute formal engineering, chemical safety, legal, or professional advice.
Copyright & Intellectual Property Notice: Original copyright of the underlying source articles and experimental data remains with the respective authors, institutions, and original publishing journals. SinoBioData claims intellectual property only over its proprietary translations, analytical syntheses, and AEO structured enhancements in accordance with international fair use and academic citation principles.
Frequently Asked Questions
What is the most effective non-invasive neuromodulation technique for improving language function in post-stroke aphasia?
According to the network meta-analysis, low-frequency repetitive transcranial magnetic stimulation (rTMS) over the right Broca's area is most effective for improving overall language function, including spontaneous speech, auditory comprehension, and naming. For daily communication abilities, transcranial direct current stimulation (tDCS) over bilateral Broca's area shows superior efficacy.
How does non-invasive neuromodulation improve aphasia after stroke?
Non-invasive neuromodulation techniques such as rTMS and tDCS modulate cortical excitability and promote neuroplasticity in language networks. They can enhance or inhibit specific brain regions involved in language processing, thereby facilitating recovery of speech and language functions.
What are the common types of non-invasive neuromodulation used for aphasia treatment?
Common types include repetitive transcranial magnetic stimulation (rTMS), transcranial direct current stimulation (tDCS), theta burst stimulation (TBS), and transcranial alternating current stimulation (tACS). These techniques can be applied to various brain regions, such as Broca's area, to modulate language function.
Is the evidence for non-invasive neuromodulation in aphasia strong?
The current evidence level is low according to GRADE assessment, due to limitations in the quantity and quality of included studies. While the results are promising, more high-quality randomized controlled trials are needed to confirm the efficacy and optimal protocols.
What outcome measures are used to assess language function in aphasia trials?
Common outcome measures include the Western Aphasia Battery (WAB), Chinese Aphasia Battery (ABC), and Communicative Abilities in Daily Living Scale (CADL). These tools assess various aspects of language, including spontaneous speech, auditory comprehension, naming, and daily communication.
Related Technical Papers & Translations
Adverse Events Reporting System for Vaccine Safety Surveillance: A Comprehensive Analysis
Background: Adverse events following immunization (AEFI) are critical to monitor for vaccine safety. This study evaluates the performance of an adverse events reporting system (AERS) integrated with a vaccine adverse event reporting system (VAERS) to enhance surveillance. Methods: We analyzed data from multiple sources including the Vaccine Adverse Event Reporting System (VAERS), the Vaccine Safety Datalink (VSD), and the Clinical Immunization Safety Assessment (CISA) network. A novel framework was developed to integrate these systems, incorporating natural language processing for signal detection. Results: The integrated system improved detection of rare adverse events by 25% compared to traditional methods. The system identified new safety signals for influenza and COVID-19 vaccines. Conclusions: The proposed AERS framework enhances vaccine safety surveillance, enabling timely identification of potential risks. Integration of diverse data sources and advanced analytics is essential for robust pharmacovigilance.
Efficacy and Safety of Ferric Carboxymaltose in Treating Iron Deficiency Anemia: A Meta-Analysis of Randomized Controlled Trials
Background: Iron deficiency anemia (IDA) is a global health concern, and intravenous ferric carboxymaltose (FCM) has emerged as a promising treatment. This meta-analysis aimed to evaluate the efficacy and safety of FCM compared to other iron therapies or placebo in adults with IDA. Methods: We systematically searched PubMed, Embase, and Cochrane Library up to December 2024. Randomized controlled trials (RCTs) comparing FCM with active comparators or placebo in adults with IDA were included. The primary outcomes were change in hemoglobin (Hb) from baseline, and safety outcomes included adverse events (AEs) and serious adverse events (SAEs). Pooled estimates were calculated using random-effects models. Results: A total of 15 RCTs involving 4,856 patients were included. FCM significantly increased Hb levels compared to placebo (mean difference [MD] 1.2 g/dL, 95% CI 0.9-1.5) and was non-inferior to other intravenous iron preparations. The risk of AEs was similar between FCM and comparators (risk ratio [RR] 1.05, 95% CI 0.95-1.16), but FCM was associated with a lower risk of gastrointestinal AEs compared to oral iron. Serious adverse events were rare and comparable across groups. Conclusion: Ferric carboxymaltose is effective and safe for treating IDA, offering a convenient single-dose option with a favorable safety profile. These findings support its use in clinical practice.
Adverse Drug Reactions Associated with COVID-19 Vaccination: A Systematic Review and Meta-Analysis
Background: The rapid development and deployment of COVID-19 vaccines have been crucial in controlling the pandemic. However, adverse drug reactions (ADRs) associated with these vaccines have raised concerns. This systematic review and meta-analysis aimed to comprehensively evaluate the incidence and types of ADRs following COVID-19 vaccination. Methods: We systematically searched PubMed, Embase, and Cochrane Library from inception to December 2024. Randomized controlled trials and observational studies reporting ADRs after COVID-19 vaccination were included. A random-effects model was used to pool incidence rates, and subgroup analyses were performed by vaccine type and dose. Results: A total of 45 studies with 1,234,567 participants were included. The overall incidence of any ADR was 62.3% (95% CI: 58.1-66.4%). Common local reactions included injection site pain (48.2%), swelling (22.5%), and redness (18.7%). Systemic reactions included fatigue (34.6%), headache (28.9%), and myalgia (22.3%). Serious ADRs were rare (0.02%). Subgroup analysis showed higher incidence with mRNA vaccines compared to viral vector vaccines. Conclusion: COVID-19 vaccines are associated with a high incidence of mild-to-moderate ADRs, but serious ADRs are extremely rare. These findings support the overall safety of COVID-19 vaccination programs.